Croda International Plc (LON:CRDA – Get Free Report) insider Ian Bull acquired 1,000 shares of the firm’s stock in a transaction on Tuesday, May 6th. The shares were bought at an average price of GBX 3,011 ($40.21) per share, for a total transaction of £30,110 ($40,205.63).
Ian Bull also recently made the following trade(s):
- On Tuesday, February 25th, Ian Bull bought 400 shares of Croda International stock. The shares were bought at an average cost of GBX 3,240 ($43.26) per share, for a total transaction of £12,960 ($17,305.38).
Croda International Trading Down 0.1 %
Shares of LON CRDA opened at GBX 3,024.55 ($40.39) on Wednesday. The business’s 50 day moving average price is GBX 2,931.48 and its 200-day moving average price is GBX 3,242.17. Croda International Plc has a fifty-two week low of GBX 2,551 ($34.06) and a fifty-two week high of GBX 4,932 ($65.86). The company has a debt-to-equity ratio of 30.90, a quick ratio of 2.25 and a current ratio of 2.72. The company has a market cap of £4.23 billion, a price-to-earnings ratio of 25.99, a PEG ratio of 1.40 and a beta of 0.74.
Croda International Increases Dividend
The business also recently announced a dividend, which will be paid on Wednesday, May 28th. Shareholders of record on Thursday, April 10th will be paid a GBX 63 ($0.84) dividend. This is an increase from Croda International’s previous dividend of $47.00. This represents a yield of 2.03%. The ex-dividend date is Thursday, April 10th. Croda International’s dividend payout ratio is currently 93.66%.
Wall Street Analyst Weigh In
A number of analysts recently issued reports on CRDA shares. Berenberg Bank reaffirmed a “buy” rating and set a GBX 3,800 ($50.74) price objective on shares of Croda International in a research note on Thursday, April 24th. Citigroup dropped their price target on shares of Croda International from GBX 3,550 ($47.40) to GBX 3,300 ($44.06) and set a “neutral” rating for the company in a research note on Tuesday, April 29th.
View Our Latest Research Report on CRDA
Croda International Company Profile
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.
Further Reading
- Five stocks we like better than Croda International
- What is the Dow Jones Industrial Average (DJIA)?
- 3 Mid-Cap Medical Stocks Outperforming the Market
- Why is the Ex-Dividend Date Significant to Investors?
- The Top-Ranked Insider Buys From April by Market Cap
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.